Datum | Källa | Rubrik | Typ | Alternativ |
---|---|---|---|---|
2024-06-19 | Ziccum | Ziccum signs Evaluation agreement with ReCode Therapeutics for LaminarPace mRNA study | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-06-11 | Ziccum | Ziccum reports on developments in the portfolio of industry partner projects | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-06-03 | Ziccum | Exercise of Employee Stock Options of Series LTI 2021:1 at Ziccum AB (publ) | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-05-29 | Ziccum | Kommuniké från årsstämma i Ziccum AB (publ) | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-05-29 | Ziccum | Bulletin from the Annual General Meeting of Ziccum AB (publ) | Pressreleaser | Ladda ner | Visa Stäng |
Pressreleaser |
Bulletin from the Annual General Meeting of Ziccum AB (publ)The following resolutions were passed at the Annual General Meeting (the “AGM”) of Ziccum AB (publ) (the “Company”) on the 29th of May 2024 in Lund. Adoption of income statement and balance sheet and discharge from liability Allocation of profit or loss Board of Directors and auditor The AGM further resolved on remuneration to the Board of Directors in accordance with the Nomination Committee’s proposal. The AGM furthermore resolved in accordance with the Nomination Committee’s proposal, that remuneration to the auditor shall be paid in accordance with approved invoice. Nomination Committee for the next Annual General Meeting Resolution on issue authorization The reason for deviating from the shareholders’ pre-emption rights is to increase the Company’s financial flexibility and the Board of Directors’ scope of action as well as to be able to complete the financing arrangement with Global Corporate Finance, which the Company announced in a press release on 22 January 2024, in a manner favorable to the shareholders. If the Board of Directors decides on an issue deviating from the shareholders’ pre-emption rights, the reason shall be to enable widening of the ownership circle, to acquire or enable the acquisition of working capital (for example by completing the financing arrangement with Global Corporate Finance), to increase the liquidity of the share, to carry out company acquisitions or to acquire or enable the acquisition of capital for company acquisitions. Incentive program for members of the Board of Directors Incentive program for employees Amendment of the Articles of Association For further information, please contact: |
||||
2024-05-28 | Ziccum | Ziccum partners with Dagens Industri for Investor Relations program | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-05-23 | Ziccum | KOMPLETTERING TILL KALLELSEN TILL ÅRSSTÄMMA I ZICCUM AB (PUBL), ATT HÅLLAS DEN 29 MAJ 2024, KL. 15.00 I BOLAGETS LOKALER PÅ SCHEELEVÄGEN 22 I LUND | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-05-06 | Ziccum | Ziccum CEO Analyst video interview: Q1, 2024 highlights | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-04-30 | Ziccum | Ziccum AB strengthens patent portfolio with three solid data PCT applications according to expanded IP strategy | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-04-29 | Ziccum | Ziccum AB (publ) Interim report Q1 2024 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2024-04-26 | Ziccum | Ziccum contracts RFR Solutions for GMP manufacturing in next phase of technology scale-out | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-04-25 | Ziccum | KALLELSE TILL ÅRSSTÄMMA I ZICCUM AB (PUBL) | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-04-15 | Ziccum | Ziccum AB (publ) releases Annual Report 2023 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2024-04-15 | Ziccum | Ziccum AB (publ) publicerar Årsredovisning 202 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2024-04-10 | Ziccum | Ziccum CEO to present at first annual event for Biopharma/Biotech disruptors hosted by major US bank in New York City | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-04-03 | Ziccum | Ziccum strengthens and streamlines business and finance functions | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-03-28 | Ziccum | Ziccum-presentation och VD-intervju från Kapitalmarknadsdag nu tillgängliga | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-03-14 | Ziccum | Ziccum inhalable mRNA/LNP project confirms excellent properties obtained by LaminarPace | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-03-01 | Ziccum | Ziccum reports significant progress in 3D-modelling project with model completion | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-02-26 | Ziccum | Ziccum meddelar sista dag för handel med BTU | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-02-26 | Ziccum | Ziccum announces last day of trading in BTU | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-02-16 | Ziccum | Ziccum offentliggör utfall i företrädesemission | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-02-16 | Ziccum | Ziccum announces outcome in rights issue | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-02-12 | Ziccum | Ziccums CEO Ann Gidner in Fireside Chat on mRNA development hosted by US Force Family Office | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-02-12 | Ziccum | Ziccums VD Ann Gidner i paneldiskussion om mRNA arrangerat av amerikanska Force Family Office | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-02-09 | Ziccum | Sista dag för handel med uniträtter i Ziccum | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-02-09 | Ziccum | Last day for trading in unit rights in Ziccum | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-02-08 | Ziccum | Ziccums Styrelse och Ledningsgrupp nyttjar samtliga sina Uniträtter i den pågående nyemissionen. | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-02-08 | Ziccum | Ziccum's Board of Directors and Management Group use all their Unit Rights in the ongoing new share issue. | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-02-05 | Ziccum | Ziccum CEO videointervju: mRNA i fokus | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-02-05 | Ziccum | Ziccum CEO video interview: mRNA in focus | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-02-03 | Ziccum | Join Ziccum CEO Ann Gidner for ‘Invest Live’, a live digital presentation and Q&A, Tues Feb 6th | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-02-03 | Ziccum | Välkommen till 'Invest Live' för att se Ziccums VD Ann Gidner presentera bolaget, som hålls live med efterföljande frågestund, tisdag den 6 februari | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-02-01 | Ziccum | Ziccums Q4-rapport – VD-uppdatering på svenska | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-01-31 | Ziccum | Ziccum has proven excellent mRNA activity in animal study with LaminarPace material | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-01-31 | Ziccum | Ziccums VD i videointervju med Eucaps | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-01-30 | Ziccum | Ziccum launches IR calendar for coming weeks | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-01-30 | Ziccum | Ziccum offentliggör informationsmemorandum med anledning av förestående företrädesemission av units | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-01-30 | Ziccum | Ziccum publishes Information Memorandum in connection with the forthcoming rights issue of units | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-01-26 | Ziccum | ZICCUM AB (publ) Year-End report Q4 2023 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2024-01-22 | Ziccum | Ziccum säkrar finansiering till 2025 genom kombinerad riktad emission och företrädesemission för fortsatt genomförande av den ambitiösa affärsplanen. | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-01-22 | Ziccum | Ziccum secures financing into 2025 through a combined directed share issue and rights issue to finance the continued execution of its ambitious business plan | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2024-01-10 | Ziccum | Ziccum reports successful mRNA/LNP Feasibility Study with major Biotech Corporation | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-12-21 | Ziccum | CEO's Seasons Greetings 2023: A pivotal year of significant results | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-12-21 | Ziccum | VDs Julhälsning 2023: Ett avgörande år med betydande resultat | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-12-04 | Ziccum | Ziccum signs Academic Collaboration with University of Copenhagen on inhalable mRNA vaccine project | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-12-01 | Ziccum | Ziccum to present at ‘Inhaled Biologics’ live webinar with KOL Assoc Prof. Per Gerde | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-11-30 | Ziccum | Ziccum AB (publ) changes Certified Adviser to Carnegie Investment Bank AB (publ) | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-11-28 | Ziccum | Feasibility studies and continued revenue generation after third agreement signed with leading industry player: CEO Interview | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-11-27 | Ziccum | Ziccum AB: BioStock: Ziccum har säkrat avtal inom alla tre marknadssegment | Pressreleaser | Visa Stäng |
|
||||
2023-11-09 | Ziccum | Ziccum launches News portal | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-11-08 | Ziccum | Ziccum CEO Analyst video interview: new industry Agreement, Q3 highlights | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-11-07 | Ziccum | Ziccum signs agreement for Vaccine Evaluation project with major US Biomanufacturing corporation | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-10-27 | Ziccum | Ziccums Q3-rapport – VD-uppdatering på svenska | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-10-25 | Ziccum | ZICCUM AB (publ) Interim report Q3 2023 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-10-23 | Ziccum | Ziccum reports positive results from external validation of mRNA activity after LaminarPace treatment | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-10-18 | Ziccum | Ziccum AB: Ziccum presenterar på BioStock Life Science Summit den 25 oktober | Pressreleaser | Visa Stäng |
|
||||
2023-09-05 | Ziccum | Ziccum appoints senior biotech manager as new COO | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-08-29 | Ziccum | Ziccum CEO Analyst interview part 2 | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-08-25 | Ziccum | Analyst interview with Ziccum CEO on significant milestones achieved | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-08-17 | Ziccum | Ziccum to present at Investor Conference BioFuture 2023 in New York | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-07-24 | Ziccum | Ziccum säkrar andra Feasibility-avtalet på två månader: VD-intervju på svenska | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-07-20 | Ziccum | Ziccums Q2-rapport - VD-uppdatering på svenska | Pressreleaser | Ladda ner | Visa Stäng |
|
||||
2023-07-18 | Ziccum | ZICCUM AB (publ) Interim report Q2 2023 | Rapporter | Ladda ner | Visa Stäng |
|
||||
2023-07-17 | Ziccum | Ziccum signs Evaluation Agreement for Feasibility Study with major global Pharmaceutical Corporation | Pressreleaser | Ladda ner | Visa Stäng |
|